The curriculum is based upon a framework that emphasizes formal instruction in the following: (1) the treatment of disorders affecting the blood, bone marrow, and the immunologic, hemostatic, and vascular systems; (2) the treatment of individual malignancies, with an emphasis on a coordinated multidisciplinary approach; (3) a clinical experience that emphasizes patient management in both the inpatient and outpatient settings; (4) the ability to perform procedures; and (5) the key tools in basic science that apply to patient management.
The fellowship provides unique opportunities to develop skills needed to address the complex psychosocial and supportive care needs of patients with hematologic and oncologic diseases. These include a weekly bio-psychosocial conference, which addresses topics such as physician-assisted suicide/euthanasia, ethics, hospice, effects on families and caregivers, ethnicity, economics, communication skills, advanced directives, team approach, spirituality, pain, depression, delirium, medical futility and other end-of-life issues. The pain and palliative care rotation addresses care for the terminally ill patient including the role of the health care team and the psychosocial, cultural and religious issues related to death and dying. Rotations in radiation oncology, blood banking, pathology and other disciplines intimately linked to hematology/oncology are also included in the curriculum. A bone marrow transplantation rotation is offered in collaboration with Mount Sinai Medical Center in Manhattan. This rotation offers formal instruction and clinical experience in allogeneic and autologous bone marrow and peripheral blood stem cell transplantation and the nature and management of post transplant complications.
Fellows attend Weekly Core Curriculum and Basic Science Conferences, as well as an integrated series of 146 lectures presented by members of the faculty. The monthly activities include Journal Club, Research Seminar, Pathology Conference, Fellows’ Presentation, Guest Lecture Series, and the Mortality and Morbidity Conference, in addition to a weekly Tumor Board and Peripheral Smear and Marrow Review.